Wisps low-cost injectable GLPs make it easier for patients to safely lose weight, improve blood sugar and metabolic health, and lower the risk of related chronic conditions, so achieving better long-term outcomes doesnt have to be out of reach
In this trial, mean weight loss was comparable to that of individuals with obesity treated with semaglutide
I noticed less post-meal discomfort within ten days, which I attribute to the digestive enzymes rather than the L-glutamine or collagen, which take longer to have any structural effect
Adequate protein intake specifically preserves lean muscle during this loss, improving long-term metabolic rate and weight maintenance
Section Spotlight The Use of GLP-1 Agonists in the Preoperative Period Akhil Chhatre, MD Johns Hopkins University School of Medicine NASS Patient Safety Committee Member Baltimore, MD Gene Tekmyster, DO, MBA Keck School of Medicine of the University of Southern California NASS Patient Safety Committee Chair Los Angeles, CA Komal Luthra, MD Johns Hopkins University School of Medicine Baltimore, MD Nikhil Gopal, MBBS Detroit Medical Center Sinai-Grace Hospital Detroit, MI Pranamya Suri, MD Johns Hopkins University School of Medicine Baltimore, MD William J